NCT05204420

Brief Summary

Patient previously healthy found to have spontaneous gastric intramural hematoma

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2021

Completed
14 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2021

Completed
17 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2022

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

January 12, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 24, 2022

Completed
Last Updated

January 24, 2022

Status Verified

January 1, 2022

Enrollment Period

14 days

First QC Date

January 12, 2022

Last Update Submit

January 12, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Spontaneous gastric intramural hematoma

    Spontaneous gastric intramural hematoma

    1 month

Interventions

Laparoscopic partial gastrectomy for gastric submucosal mass

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients previously healthy presenting with bleeding gastric mass

You may qualify if:

  • any patient presenting with gastric bleeding tumors

You may not qualify if:

  • patients on anticoagulants and patient with gastric medical history

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Balamand

Beirut, Lebanon

Location

Study Officials

  • Omar Tabbikha, MD

    University of Balamand

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
General Surgery Resident

Study Record Dates

First Submitted

January 12, 2022

First Posted

January 24, 2022

Study Start

December 1, 2021

Primary Completion

December 15, 2021

Study Completion

January 1, 2022

Last Updated

January 24, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Publishing a case report of our finding

Locations